Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Bleiberg

Showing results (111-120 of 159) with videos related to

Pageof 16
Sort By:
European Journal of Cancer & Clinical Oncology|July 1, 1987
An EORTC Gastrointestinal Group phase II evaluation of epirubicin combined with 5-fluorouracil in advanced adenocarcinoma of the pancreasJ Wils, H Bleiberg, O Dalesio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1994
Dose-finding study of tropisetron in cisplatin-induced nausea and vomitingS J Van Belle, L Stamatakis, H Bleiberg, et al.
Endoscopy|September 1, 1979
Endoscopic appearance of irradiated gastric mucosaL I De Sagher, B Van den Heule, P Van Houtte, et al.
European Journal of Cancer & Clinical Oncology|July 1, 1989
An EORTC Gastrointestinal Group phase II evaluation of epirubicin combined with ifosfamide in advanced adenocarcinoma of the pancreas. EORTC Gastrointestinal GroupJ Wils, H Bleiberg, M Buyse, et al.
Anti-Cancer Drugs|July 23, 2004
Treatment of advanced digestive non-colon cancer with a weekly 24-h infusion of high-dose 5-fluorouracil modulated by folinic acid and cisplatin: an easy-to-use and well-tolerated combinationT Delaunoit, R Maréchal, A Hendlisz, et al.
European Journal of Cancer (Oxford, England : 1990)|September 29, 2001
A weekly 24-h infusion of high-dose 5-fluorouracil (5-FU)+leucovorin and bi-weekly cisplatin (CDDP) was active and well tolerated in patients with non-colon digestive carcinomasF X Caroli-Bosc, J L Van Laethem, P Michel, et al.
Anti-Cancer Drugs|June 23, 1998
Oxaliplatin combined to 5-fluorouracil and folinic acid: an effective therapy in patients with advanced colorectal cancerB Gerard, H Bleiberg, D Van Daele, et al.
European Journal of Cancer & Clinical Oncology|November 1, 1985
cis-Platinum as second-line chemotherapy in advanced gastric adenocarcinoma. A phase II study of the EORTC Gastrointestinal Tract Cancer Cooperative GroupA J Lacave, J Wils, E Diaz-Rubio, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1986
Hepatic arterial ligation and portal vein infusion: a clinical trial by the Gastrointestinal Tract Cancer Group of the European Organization for Research and Treatment of CancerA Gerard, O Dalesio, N Duez, et al.
Cancer Investigation|January 1, 1990
Randomized phase II study of a combination of cisplatin (DDP), 5-fluorouracil (5-FU), and allopurinol (HPP) versus 5-FU in advanced colorectal carcinoma. An EORTC Gastrointestinal Tract Cancer Cooperative Group studyH Bleiberg, B Vanderlinden, M Buyse, et al.
Pageof 16

Showing results (111-120 of 159) with videos related to

Sort By:
Pageof 16
European Journal of Cancer & Clinical Oncology|July 1, 1987
An EORTC Gastrointestinal Group phase II evaluation of epirubicin combined with 5-fluorouracil in advanced adenocarcinoma of the pancreasJ Wils, H Bleiberg, O Dalesio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1994
Dose-finding study of tropisetron in cisplatin-induced nausea and vomitingS J Van Belle, L Stamatakis, H Bleiberg, et al.
Endoscopy|September 1, 1979
Endoscopic appearance of irradiated gastric mucosaL I De Sagher, B Van den Heule, P Van Houtte, et al.
European Journal of Cancer & Clinical Oncology|July 1, 1989
An EORTC Gastrointestinal Group phase II evaluation of epirubicin combined with ifosfamide in advanced adenocarcinoma of the pancreas. EORTC Gastrointestinal GroupJ Wils, H Bleiberg, M Buyse, et al.
Anti-Cancer Drugs|July 23, 2004
Treatment of advanced digestive non-colon cancer with a weekly 24-h infusion of high-dose 5-fluorouracil modulated by folinic acid and cisplatin: an easy-to-use and well-tolerated combinationT Delaunoit, R Maréchal, A Hendlisz, et al.
European Journal of Cancer (Oxford, England : 1990)|September 29, 2001
A weekly 24-h infusion of high-dose 5-fluorouracil (5-FU)+leucovorin and bi-weekly cisplatin (CDDP) was active and well tolerated in patients with non-colon digestive carcinomasF X Caroli-Bosc, J L Van Laethem, P Michel, et al.
Anti-Cancer Drugs|June 23, 1998
Oxaliplatin combined to 5-fluorouracil and folinic acid: an effective therapy in patients with advanced colorectal cancerB Gerard, H Bleiberg, D Van Daele, et al.
European Journal of Cancer & Clinical Oncology|November 1, 1985
cis-Platinum as second-line chemotherapy in advanced gastric adenocarcinoma. A phase II study of the EORTC Gastrointestinal Tract Cancer Cooperative GroupA J Lacave, J Wils, E Diaz-Rubio, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1986
Hepatic arterial ligation and portal vein infusion: a clinical trial by the Gastrointestinal Tract Cancer Group of the European Organization for Research and Treatment of CancerA Gerard, O Dalesio, N Duez, et al.
Cancer Investigation|January 1, 1990
Randomized phase II study of a combination of cisplatin (DDP), 5-fluorouracil (5-FU), and allopurinol (HPP) versus 5-FU in advanced colorectal carcinoma. An EORTC Gastrointestinal Tract Cancer Cooperative Group studyH Bleiberg, B Vanderlinden, M Buyse, et al.
Pageof 16